FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Endocrine Myopathies

Research

With MDA support, scientists have made significant progress toward understanding and treating myopathies.

Looking for more information, support or ways to get involved?

Request Services Get Our Emails

Find MDA
in your Community